<![CDATA[Dyslipideimia is a coimmoin meitaboilic abnoirmality amoing patieints with typei 2 diabeiteis meillitus (T2DM) and cointributeis toi increiaseid cardioivascular risk. Lipid-loiweiring theirapy, particularly statins, plays an impoirtant roilei in thei manageimeint oif dyslipideimia; hoiweiveir, treiatmeint patteirns and approipriateineiss may vary in roiutinei clinical practicei. This study aimeid toi deiscribei thei patteirns oif dyslipideimia treiatmeint and eivaluatei treiatmeint approipriateineiss amoing patieints with T2DM at Dr. Mintoihardjoi Naval Hoispital, Jakarta, Indoineisia. This oibseirvatioinal analytical study useid a reitroispeictivei croiss-seictioinal deisign. Data weirei oibtaineid froim thei meidical reicoirds oif 200 patieints with T2DM. Dyslipideimia treiatmeint was classifieid intoi statin, noin-statin, coimbinatioin oif statin and noin-statin, and noi lipid-loiweiring theirapy. Treiatmeint approipriateineiss was classifieid as approipriatei oir inapproipriatei accoirding toi thei preideifineid criteiria useid in thei study. Data weirei analyzeid using IBM SPSS Statistics veirsioin 27.0 and preiseinteid as freiqueincieis and peirceintageis. Oif 200 patieints with T2DM, 105 (52.5%) reiceiiveid statin theirapy, 14 (7.0%) reiceiiveid noin-statin theirapy, 23 (11.5%) reiceiiveid coimbinatioin theirapy, and 58 (29.0%) reiceiiveid noi lipid-loiweiring theirapy. Oiveirall, 165 patieints (82.5%) had treiatmeint classifieid as approipriatei, wheireias 35 (17.5%) had treiatmeint classifieid as inapproipriatei. Statins weirei thei moist freiqueintly useid lipid-loiweiring theirapy amoing patieints with T2DM. Moist patieints reiceiiveid treiatmeint classifieid as approipriatei; hoiweiveir, neiarly oinei-third reiceiiveid noi lipid-loiweiring theirapy and 17.5% had treiatmeint classifieid as inapproipriatei. Peirioidic eivaluatioin oif lipid-loiweiring theirapy is theireifoirei impoirtant toi suppoirt oiptimal dyslipideimia manageimeint in patieints with T2DM.]]>
